- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/08 - 1,2,4-TriazolesHydrogenated 1,2,4-triazoles
Patent holdings for IPC class C07D 249/08
Total number of patents in this class: 1203
10-year publication summary
|
120
|
97
|
74
|
67
|
80
|
70
|
53
|
72
|
52
|
29
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20904 |
67 |
| Karyopharm Therapeutics Inc. | 142 |
40 |
| Corteva Agriscience LLC | 2661 |
37 |
| Kureha Corporation | 1022 |
30 |
| Bayer Cropscience AG | 2042 |
18 |
| Bristol-myers Squibb Company | 4878 |
16 |
| Ardea Biosciences, Inc. | 73 |
16 |
| BASF Agro B.V. | 198 |
16 |
| Dow AgroSciences LLC | 1224 |
14 |
| Merck Sharp & Dohme LLC | 3749 |
12 |
| Amgen Inc. | 4074 |
11 |
| Nippon Soda Co., Ltd. | 894 |
11 |
| Synta Pharmaceuticals Corp. | 179 |
11 |
| Novartis AG | 10867 |
10 |
| Boehringer Ingelheim International GmbH | 4695 |
10 |
| Janssen Pharmaceutica N.V. | 3399 |
9 |
| Theravance Biopharma R&D IP, LLC | 460 |
9 |
| Merck Sharp & Dohme Corp. | 2200 |
8 |
| Bayer Pharma AG | 1061 |
8 |
| Board of Regents, The University of Texas System | 5772 |
8 |
| Other owners | 842 |